WHO to document Karnataka's eye-care model
In a letter dated June 30 to the principal secretary (health) Harsh Gupta, WHO's India representative Dr Roderico H Ofrin commended the state govt for conceptualising and implementing the programme "in an exemplary manner".
"The Asha Kirana initiative embodies IPEC principles by integrating eye care into primary health services and the wider public health system," Dr Ofrin stated. He said WHO proposes to conduct a comprehensive assessment of the model using its established tools — Eye Care Situation Analysis Tool (ECSAT) and Eye Care Indicator Menu (ECIM) — to document the processes, outcomes and lessons from the initiative. The documentation will be carried out independently by WHO at no cost to the state.
You Can Also Check:
Bengaluru AQI
|
Weather in Bengaluru
|
Bank Holidays in Bengaluru
|
Public Holidays in Bengaluru
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
6 hours ago
- The Hindu
No direct correlation between cardiovascular events and COVID-19 exposure and vaccination: Study
A pilot observational study by the State-run Sri Jayadeva Institute of Cardiovascular Sciences and Research (SJICSR) has not found any association between premature cardiovascular disease and a prior history of COVID-19 infection, or COVID vaccination. Amid mounting public anxiety over the rising trend of sudden cardiovascular events (heart attack, sudden cardiac death) post-COVID-19 pandemic, the Karnataka government had in February this year set up an expert committee headed by Jayadeva Director K. S. Ravindranath to evaluate the temporal and potential causal links with prior SARS-CoV-2 infection and/or COVID-19 vaccination. The cross-sectional study involving 251 patients, including 32 females, aged below 45 years, was aimed at presenting evidence-based insights, identifying risk factors, and proposing recommendations for surveillance and prevention. The committee submitted its report to Harsh Gupta, Principal Secretary, Health and Family Welfare on July 4. Under-recognised mechanisms 'Although conventional risk factors, such as hypertension, diabetes, dyslipidemia, and smoking, remain prevalent in a majority of the 251 patients, a significant minority of patients presented with none of these, suggesting the possible involvement of novel or under-recognized mechanisms,' Dr Ravindranath told The Hindu. According to the report, while 87 of the patients were diabetic, 102 were hypertensive, 35 were having cholesterol disorder, 40 had family history of heart diseases, 111 were smokers, and 77 patients did not have any of the conventional risk factors. As many as 19 out of 251 patients had a history of previous COVID-19 infection. Of the 19, seven each had diabetes and hypertension, two had a family history, eight had no risk factors. Almost all (249) of the 251 patients had been vaccinated against COVID. While 53 received only one dose, 180 received two doses, and 17 received all three doses of a vaccine. As many as 144 had been vaccinated with Covishield, 64 with Covaxin, and 52 were unaware of which vaccine they had received. Comparative data To compare the risk factor profile of similar premature coronary artery disease patients prior to the pandemic, the team used data from the institute's Premature Coronary Artery Disease (PCAD) among the young registry maintained at the institute between April 1, 2019 and May 31, 2019. As the PCAD registry was maintained for patients aged under 40 years, a subset of patients from the present study aged below 40 years were grouped and compared with the 2019 age and sex-matched population. Analysing all national and international peer reviewed scientific literature, journal articles, clinical studies and clinical registries to study the possible association of sudden cardiovascular events with past history of COVID-19 infection and vaccination, the Jayadeva committee noted that most studies and reports published globally have also not found any causal association between COVID vaccination and sudden cardiovascular events. 'On the contrary, COVID vaccination has been shown to be protective against cardiac events in the long term,' the report stated. No single cause 'Our study has not found any single cause behind the observed rise in sudden cardiac deaths. Rather, it appears to be a multi-factorial issue, with behavioural, genetic, and environmental risks. While in the immediate post-COVID phase, there is an increase in the incidence of sudden cardiovascular events due to a pro-inflammatory state, the same cannot be held to be true in the long term (>1 year). It has been three years since the end of the pandemic,' Dr Ravindranath said. He said current data does not support the belief that 'long COVID' is responsible for the rise in sudden cardiovascular events among the young. 'Rather, a rise in the prevalence of the common risk factors that lead to cardiovascular disease (hypertension, diabetes, smoking , dyslipidemia) is the best explanation for the rise in sudden cardiovascular events. In light of these findings, a multi-faceted public health strategy is essential,' he asserted. Recommendations Pointing out that the strategy should include establishing a robust surveillance system for sudden cardiac deaths, particularly among young adults, the Jayadeva director said implementing autopsy-based registries and integrating early cardiovascular screening at the school level is vital. 'Importantly, large-scale, prospective, multicentric studies are needed to better delineate the long-term cardiovascular effects of both COVID-19 infection and vaccination,' he explained. Recommendations
Indian Express
12 hours ago
- Indian Express
WHO's ‘3 by 35' initiative targets tobacco, alcohol and sugary drinks
The World Health Organization (WHO) has launched a '3 by 35' initiative urging countries to raise real prices on tobacco, alcohol, and sugary drinks by at least 50 per cent by 2035 through health taxes in a move designed to curb chronic diseases and generate critical public revenue. Led by WHO, the initiative brings together a group of global partners to help countries put health taxes into action. These organizations offer a mix of technical know-how, policy advice, and real-world experience. By working together, they aim to raise awareness about the benefits of health taxes and support efforts at the national level. As per WHO officials, the consumption of tobacco, alcohol, and sugary drinks are fueling the epidemic of non-communicable diseases. NCDs, including heart disease, cancer, and diabetes, account for over 75 per cent of all deaths worldwide. A recent report shows that a one-time 50 per cent price increase on these products could prevent 50 million premature deaths over the next 50 years. 'Health taxes are one of the most efficient tools we have,' Dr Jeremy Farrar, Assistant Director-General, Health Promotion and Disease Prevention and Control, WHO, said in an official statement. The initiative has an ambitious goal of raising US $1 trillion over the next 10 years. Between 2012 and 2022, nearly 140 countries raised tobacco taxes, which resulted in an increase of real prices by over 50 per cent on average, showing that large-scale change is possible, according to the WHO report. Many countries have expressed interest in transitioning toward more self-reliant, domestically funded health systems and are turning to WHO for guidance. The '3 by 35' initiative introduces key action areas to help countries, pairing proven health policies with best practices on implementation. These include direct support for country-led reforms, mobilizing domestic public resources to fund essential health and development programmes, including universal health coverage. India has implemented tobacco taxation under the GST framework, with 28 per cent GST and an additional compensation cess on cigarettes and select products. However, bidis (smoked by low-income groups) and smokeless tobacco (SLT) (used by over two-thirds of tobacco users) remain under-taxed. Experts said that India's current approach to taxing tobacco, alcohol and sugar-sweetened beverages represents a fragmented, revenue-centric model that lacks a coherent public health framework. 'India's current taxation of tobacco, alcohol, and sugar-sweetened beverages represents substantial untapped potential for public health advancement. The absence of a coherent health tax framework limits their effectiveness in addressing India' s growing NCD burden. The WHO 3 by 35 Initiative provides both the rationale and the roadmap for transformation, offering a pathway to shift from revenue-driven to public health-oriented taxation that can achieve the dual objectives of sustainable health financing and disease prevention,' Dr Prashant Kumar Singh, senior scientist at Indian Council of Medical Research- National Institute of Cancer Prevention and Research told The Indian Express. Anuradha Mascarenhas is a journalist with The Indian Express and is based in Pune. A senior editor, Anuradha writes on health, research developments in the field of science and environment and takes keen interest in covering women's issues. With a career spanning over 25 years, Anuradha has also led teams and often coordinated the edition. ... Read More
Hindustan Times
12 hours ago
- Hindustan Times
Caution not anti-science, says CM as slugfest over vaccine heats up
A social media spat between chief minister Siddaramaiah and Biocon Executive chairperson Kiran Mazumdar-Shaw has brought renewed attention to the safety of COVID-19 vaccines and their possible long-term side effects. The exchange follows mounting concerns in Hassan district, where a spike in sudden heart-related deaths has raised public alarm. Caution not anti-science, says CM as slugfest over vaccine heats up The chief minister's initial remarks on July 1 questioned whether the deaths could be connected to the fast-tracked rollout of vaccines during the pandemic. While acknowledging that the vaccines were introduced under extraordinary global circumstances, Siddaramaiah suggested that the speed of approval may have overlooked long-term effects. 'It cannot be denied that the hasty approval and distribution of the COVID-19 vaccines to the public could also be a reason for these deaths,' he said in a post on the social media platform X, citing emerging global research linking vaccines to heart-related complications. To address public concerns, Siddaramaiah said his government had formed an expert committee led by Dr Ravindranath KS of Sri Jayadeva Institute of Cardiovascular Sciences and Research. The panel's mandate is to determine whether there is any scientific link between the vaccine rollout and the recent deaths in Hassan. In response, Shaw on Thursday challenged the chief minister's framing of the vaccine development process, calling it misleading and inaccurate. She said that India's vaccines were granted Emergency Use Authorisation (EUA) after meeting globally accepted safety and efficacy norms. 'To suggest that these vaccines were 'hastily' approved is factually incorrect and contributes to public misinformation,' she wrote, while also noting that side effects, though rare, did occur with any vaccine. In her follow-up post, Shaw said she agreed with the need for investigations into sudden deaths but reiterated that the regulatory process followed for vaccine approval met international standards. 'My response was that due process was followed as prescribed by WHO for safety and efficacy for Emergency Use Authorisation,' she wrote. 'Losing lives in a sudden manner is always tragic, and I am glad an investigation is being conducted in Hassan district.' By Friday, the discussion intensified as Siddaramaiah returned to the issue, stating that his role as chief minister obligated him to respond to the distress of families who had lost loved ones. 'When parents lose their young children or families lose breadwinners without warning, seeking clarity is not misinformation; it is an act of governance rooted in empathy,' he said. The chief minister further argued that questioning vaccine safety should not be equated with denialism or anti-science sentiment. He referred to studies published in journals such as Nature, Circulation, and the Journal of the American College of Cardiology, which have examined risks like myocarditis and cardiac arrest among younger populations post-vaccination. He also cited an admission by AstraZeneca about rare but serious side effects. 'Scientific caution is not anti-science,' Siddaramaiah said, adding that 'publicly funded stakeholders must acknowledge both the benefits and the potential risks without fear or favour.' He clarified that his use of the term 'hastily' was in reference to the emergency rollout timelines that global health agencies, including the WHO, had termed a 'calculated risk' during the height of the pandemic. 'Haste is not a sin when saving lives,' he said, 'but acknowledging potential unintended consequences is wisdom.' Meanwhile, the Union health ministry dismissed any connection between COVID-19 vaccines and the recent deaths. Referring to data from the Indian Council of Medical Research (ICMR) and the National Centre for Disease Control (NCDC), the ministry asserted that the vaccines were both safe and effective, with serious adverse reactions being extremely rare.
